ZNF720 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.330000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.820400E-01
Normal-vs-Stage2
2.309000E-01
Normal-vs-Stage3
9.594100E-02
Normal-vs-Stage4
9.881200E-01
Stage1-vs-Stage2
9.989200E-01
Stage1-vs-Stage3
9.040300E-02
Stage1-vs-Stage4
3.131800E-01
Stage2-vs-Stage3
1.394850E-01
Stage2-vs-Stage4
1.618050E-01
Stage3-vs-Stage4
1.185560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.421400E-01
Normal-vs-AfricanAmerican
3.410200E-01
Normal-vs-Asian
1.159030E-01
Caucasian-vs-AfricanAmerican
8.805400E-01
Caucasian-vs-Asian
4.808500E-02
AfricanAmerican-vs-Asian
3.210200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.576400E-01
Normal-vs-Female
2.305400E-01
Male-vs-Female
8.775600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.475400E-01
Normal-vs-Age(41-60Yrs)
4.238800E-01
Normal-vs-Age(61-80Yrs)
1.992830E-01
Normal-vs-Age(81-100Yrs)
8.569700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.907800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.657000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.030600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.124400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.003500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.186200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.633840E-01
Normal-vs-Daily Drinker
5.241700E-02
Normal-vs-Weekly Drinker
2.781000E-01
Normal-vs-Occasional Drinker
3.426600E-01
Normal-vs-Social Drinker
6.359600E-01
Non Drinker-vs-Daily Drinker
3.199400E-01
Non Drinker-vs-Weekly Drinker
9.807600E-01
Non Drinker-vs-Occasional Drinker
1.940980E-01
Non Drinker-vs-Social Drinker
1.358410E-01
Daily Drinker-vs-Weekly Drinker
4.639400E-01
Daily Drinker-vs-Occasional Drinker
2.174500E-02
Daily Drinker-vs-Social Drinker
2.657800E-02
Weekly Drinker-vs-Occasional Drinker
3.060000E-01
Weekly Drinker-vs-Social Drinker
2.556400E-01
Occasional Drinker-vs-Social Drinker
6.663800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.181760E-02
Normal-vs-Grade 2
1.403090E-03
Normal-vs-Grade 3
5.478000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.700580E-01
Grade 1-vs-Grade 3
8.408000E-02
Grade 1-vs-Grade 4
1.181760E-02
Grade 2-vs-Grade 3
3.620400E-01
Grade 2-vs-Grade 4
1.403090E-03
Grade 3-vs-Grade 4
5.478000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.526400E-01
Normal-vs-NonDiabetic
1.420190E-01
Diabetic-vs-NonDiabetic
7.481800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.502960E-01
Normal-vs-NoPancreatitis
1.867400E-01
Pancreatitis-vs-NoPancreatitis
7.357000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.842800E-01
Normal-vs-N1
2.381800E-01
N0-vs-N1
9.625200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.480600E-01
Normal-vs-TP53-NonMutant
3.033400E-01
TP53-Mutant-vs-TP53-NonMutant
1.714580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
